The Europe Electronic Clinical Outcome Assessment Solution Market (eCOA) is expected to witness market growth of 18.6% CAGR during the forecast period (2020-2026).
Electronic-based services for data capturing & analyzing effectively beat every limitation of paper-based procedures, with a surge in patient compliance. With the help of these solutions, the risk of data variance can be eliminated & site monitoring costs can be reduced. These solutions provide simplified information that helps in enhancing the quality of data by gathering the information in an organized manner. These factors is expected to act as drivers for the growth of the eCOA market during the forecast period. The requirement for incorporation of patient care into clinical research results in a patient-centric approach being deployed by sponsors, which causes an increment in the installation of eCOA platforms.
The adoption & demand for eCOA solutions is expected to be fuelled due to the complexity of healthcare information management. Using these systems, healthcare facilities can expect accurate & timely delivery of health information & decrease the pressure of patients who are undergoing clinical trials. The demand for R&D to create innovative treatments & drugs is increasing with the massive growth of the healthcare industry. The increasing number of research studies is creating a need for a unified data capture system. Therefore, all the mentioned aspects is expected to drive the product demand during the forecast period.
There is a paradigm shift from paper-based procedures to electronic data capturing systems. This is owing to the increasing burden on pharmaceutical companies to reduce overall costs for the development of a new drug. The data capturing through eCOA platforms enhance the quality of the information obtained, centralizes the data collection methods, and provides valuable insights to its users such as data analysis.
Based on Delivery Mode, the market is segmented into Web-hosted eCOA, Cloud-based eCOA, and Licensed enterprises eCOA. Based on End Use, the market is segmented into Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharma & Biotech Companies and Medical Device Manufacturers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Academic Institutes Market by Country in 2019, thereby, achieving a market value of $25 Million by 2026. The UK market is showcasing a CAGR of 17.7% during (2020 - 2026). Additionally, The France market is poised to grow at a CAGR of 19.1% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Dassault Systemes SE, IQVIA Holdings, Inc., Parexel International Corporation (Pamplona Capital Management), IBM Corporation (Merge Healthcare), Signant Health, ERT Clinical, eClinical Solutions LLC, Castor EDC and Anju Software, Inc. (OmniComm Systems).
Scope of the Study
Market Segments covered in the Report:
By Delivery Mode
By End Use
By Country
Companies Profiled
Unique Offerings from the Publisher
Electronic-based services for data capturing & analyzing effectively beat every limitation of paper-based procedures, with a surge in patient compliance. With the help of these solutions, the risk of data variance can be eliminated & site monitoring costs can be reduced. These solutions provide simplified information that helps in enhancing the quality of data by gathering the information in an organized manner. These factors is expected to act as drivers for the growth of the eCOA market during the forecast period. The requirement for incorporation of patient care into clinical research results in a patient-centric approach being deployed by sponsors, which causes an increment in the installation of eCOA platforms.
The adoption & demand for eCOA solutions is expected to be fuelled due to the complexity of healthcare information management. Using these systems, healthcare facilities can expect accurate & timely delivery of health information & decrease the pressure of patients who are undergoing clinical trials. The demand for R&D to create innovative treatments & drugs is increasing with the massive growth of the healthcare industry. The increasing number of research studies is creating a need for a unified data capture system. Therefore, all the mentioned aspects is expected to drive the product demand during the forecast period.
There is a paradigm shift from paper-based procedures to electronic data capturing systems. This is owing to the increasing burden on pharmaceutical companies to reduce overall costs for the development of a new drug. The data capturing through eCOA platforms enhance the quality of the information obtained, centralizes the data collection methods, and provides valuable insights to its users such as data analysis.
Based on Delivery Mode, the market is segmented into Web-hosted eCOA, Cloud-based eCOA, and Licensed enterprises eCOA. Based on End Use, the market is segmented into Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharma & Biotech Companies and Medical Device Manufacturers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Academic Institutes Market by Country in 2019, thereby, achieving a market value of $25 Million by 2026. The UK market is showcasing a CAGR of 17.7% during (2020 - 2026). Additionally, The France market is poised to grow at a CAGR of 19.1% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Dassault Systemes SE, IQVIA Holdings, Inc., Parexel International Corporation (Pamplona Capital Management), IBM Corporation (Merge Healthcare), Signant Health, ERT Clinical, eClinical Solutions LLC, Castor EDC and Anju Software, Inc. (OmniComm Systems).
Scope of the Study
Market Segments covered in the Report:
By Delivery Mode
- Web-hosted eCOA
- Cloud-based eCOA
- Licensed enterprises eCOA
By End Use
- Contract Research Organizations (CROs)
- Hospitals
- Academic Institutes
- Pharma & Biotech Companies
- Medical Device Manufacturers
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Oracle Corporation
- Dassault Systemes SE
- IQVIA Holdings, Inc.
- Parexel International Corporation (Pamplona Capital Management)
- IBM Corporation (Merge Healthcare)
- Signant Health
- ERT Clinical
- eClinical Solutions LLC
- Castor EDC
- Anju Software, Inc. (OmniComm Systems)
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Delivery Mode
Chapter 5. Europe Electronic Clinical Outcome Assessment (eCOA) Solutions Market by End-use
Chapter 6. Europe Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Oracle Corporation
- Dassault Systemes SE
- IQVIA Holdings, Inc.
- Parexel International Corporation (Pamplona Capital Management)
- IBM Corporation (Merge Healthcare)
- Signant Health
- ERT Clinical
- eClinical Solutions LLC
- Castor EDC
- Anju Software, Inc. (OmniComm Systems)
Methodology
LOADING...
![Global Electronic Clinical Outcome Assessment (eCOA) Solution Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Use ([Clinical trial: Onco, Rare, Mental Health], RWE, Registery), End-user, and Region - Forecast to 2029 - Product Image](http://www.researchandmarkets.com/product_images/12625/12625499_60px_jpg/global_electronic_clinical_outcome_assessment_solution_market.jpg)
